300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Travel
Platforms
InsurTech
Oil and Gas
Cryptocurrency
Social Impact
SaaS
Film
Restaurants
Photography
Payments
Renewable Energy
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Facebook
Blockchain
Social Network
B2B
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Legal
Sports
Construction
Automotive
eSports
Hospitality
Biotechnology
Consumer
Software
Crowdfunding
Venture Capital
Social
Infrastructure
Fashion
Beauty
LGBT
Celebrity
Cannabis
Climate
Mobile Apps
Life Science
Publishing
Food and Beverage
Wine and Spirits
Real Estate
Sporting Goods
Art
Music
Finance
Digital Media
FinTech
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Impact
Biotech
Proptech
Sustainability
Hardware
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Medical
Theatre
Recruiting
Any country
South Korea
Africa
Oceania
Brazil
Saudi Arabia
Singapore
LATAM
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Zambia
Puerto Rico
Tunisia
Russian Federation
Nigeria
Isle of Man
Pakistan
Togo
Tajikistan
Zimbabwe
Romania
Oman
Australia
Cameroon
Colombia
India
New Zealand
China
Sri Lanka
Vietnam
Armenia
Costa Rica
Chile
Switzerland
Czech Republic
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Seychelles
Germany
Japan
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Portugal
Philippines
Poland
Rwanda
Sierra Leone
Senegal
Thailand
El Salvador
Uruguay
Tanzania
United Kingdom
United States
Canada
Indonesia
Middle East
Ireland
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Angola
Europe
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Bahrain
Bahamas
Estonia
Faroe Islands
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
San Marino
Slovenia
Ukraine
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotechnology Startup Investors in Denmark (June 2026)

The most active venture capital funds and angel investors investing in Denmark Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Denmark Biotechnology startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Novo Holdings
VC Fund
31 United States, Denmark, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $9M–$130M
BioInnovation Institute
VC Fund
19 Denmark, Germany, Switzerland Convertible Note, Pre-Seed, Debt Financing Biotechnology, Medical, Health Care $516k–$5.2M
Vaekstfonden
VC Fund
16 Denmark, United States, United Kingdom Seed, Pre-Seed Software, Information Technology, SaaS $440k–$4.6M
Export and Investment Fund
VC Fund
14 Denmark, United States, United Kingdom Seed, Series A Software, Biotechnology, Health Care $390k–$84M
Seed Capital
VC Fund
9 Denmark, United States, United Kingdom Seed, Series A Software, Health Care, SaaS $515k–$17M
PSV
VC Fund
8 Denmark, United States, United Kingdom Seed, Pre-Seed Software, Information Technology, SaaS $88k–$4.7M
Sunstone Life Science Ventures
VC Fund
6 Denmark, Sweden, Switzerland Series B, Series A Biotechnology, Health Care, Medical $5.5M–$52M
Oskare Capital
VC Fund
6 Italy, Denmark, United Kingdom Seed, Series A, Pre-Seed Health Care, Biotechnology, Medical $1.2M–$5.9M
Gilde Healthcare
VC Fund
6 United States, The Netherlands, Germany Series B, Series C, Series A Biotechnology, Health Care, Medical $8.8M–$120M
Nordic Foodtech VC
VC Fund
6 Finland, Denmark, Sweden Seed, Series A, Pre-Seed Biotechnology, Food and Beverage, Life Science $549k–$18M
RA Capital Management
VC Fund
5 United States, United Kingdom, Canada Series B, Series C, Post-IPO Equity Biotechnology, Health Care, Therapeutics $26M–$235M
West Hill Capital
VC Fund
4 United Kingdom, Denmark, Germany Series A, Seed Software, Health Care, Financial Services $1.8M–$15M
DSM Venturing
VC Fund
4 United States, Canada, Israel Series A, Series B Biotechnology, Health Care, Manufacturing $3.5M–$32M
HealthCap
VC Fund
4 United States, Sweden, France Series B, Series A Biotechnology, Health Care, Medical $5.7M–$88M
PINC
VC Fund
4 Sweden, Denmark, United Kingdom Seed, Pre-Seed, Series A Biotechnology, Agriculture, Food and Beverage $549k–$7.4M
Ysios Capital
VC Fund
4 Spain, United States, Switzerland Series A, Series B, Series C Biotechnology, Health Care, Medical $2.2M–$135M
ACME Capital
VC Fund
4 United States, Denmark, Canada Seed, Series A, Series B Software, Health Care, Mobile $1.6M–$70M
VF Venture
VC Fund
4 Denmark, United Kingdom, Iceland Seed, Series A Software, SaaS, Biotechnology $1.2M–$22M
Per Falholt
Angel
4 Denmark Pre-Seed, Series A, Seed Biotechnology, Robotics, Biopharma $5.9M–$20M
EIR Ventures
VC Fund
3 Denmark, Sweden, United States Series A, Seed Biotechnology, Health Care, Therapeutics $20M–$73M
Blue Horizon Corporation
VC Fund
3 United States, United Kingdom, Germany Seed, Series A, Pre-Seed Food and Beverage, Food Processing, Biotechnology $450k–$28M
Ugly Duckling Ventures
VC Fund
3 Denmark, Sweden, Finland Seed, Pre-Seed Software, Information Technology, Artificial Intelligence $876k–$5.5M
HTGF (High-Tech Gruenderfonds)
VC Fund
3 Germany, Switzerland, United States Seed, Series A Software, Biotechnology, Information Technology $994k–$40M
The Footprint Firm
VC Fund
3 Denmark, Spain, Norway Seed, Pre-Seed, Series A Software, Renewable Energy, Energy Management $730k–$18M
Thia Ventures
VC Fund
3 United States, France, Denmark Series A, Seed, Series B Biotechnology, Health Care, Food and Beverage $3.3M–$53M
NOON Ventures
VC Fund
3 Denmark Seed, Series A Biotechnology, AgTech, Farming
Unconventional Ventures
VC Fund
3 Sweden, United Kingdom, Denmark Seed, Pre-Seed, Series A Health Care, Software, Wellness $1M–$18M
Karolinska
VC Fund
3 Sweden, Denmark, United States Seed, Series A Biotechnology, Health Care, Pharmaceutical $1.3M–$73M
Innovation Fund Denmark
VC Fund
3 Denmark, United States Grant, Pre-Seed, Seed Software, Biotechnology, SaaS $22k–$1.6M
Bioqube Ventures
VC Fund
3 United States, France, Norway Seed, Series A, Series B Biotechnology, Therapeutics, Life Science $4M–$108M
Nicholas Francis
Angel
3 Denmark, United States Seed, Series A SaaS, Robotics, Software $854k–$7.1M
Atlantic
VC Fund
3 Germany, Switzerland, United States Seed, Series A, Pre-Seed Software, Health Care, Financial Services $850k–$32M
Sofinnova Partners
VC Fund
3 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $6M–$120M
Omega Funds
VC Fund
3 United States, Switzerland, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $14M–$208M
Newtree Impact
VC Fund
2 Denmark Seed Biotechnology
SOSV
VC Fund
2 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
Balderton Capital
VC Fund
2 United Kingdom, United States, Germany Series A, Series B, Series C Software, FinTech, Financial Services
Aescap Venture
VC Fund
2 United Kingdom, Austria, Belgium Series A, Series B Biotechnology, Pharmaceutical, Chemical
CAPNOVA
VC Fund
2 Denmark, United States, India Seed, Pre-Seed Software, Information Technology, B2B $147k–$2.4M
Symrise
VC Fund
2 United States, Sweden, Denmark Series A, Seed Biotechnology, Health Care, Pet $4.2M–$7.4M
Novo Ventures
VC Fund
2 United States, United Kingdom, Switzerland Series B, Series A, Series C Biotechnology, Health Care, Medical $8.5M–$143M
Steen Riisgaard
Angel
2 Denmark Pre-Seed Life Science, Therapeutics, Biotechnology
+ND Capital
VC Fund
2 United States, Switzerland, Denmark Series B, Series C, Series A Biotechnology, Health Care, Medical
Northzone
VC Fund
2 United States, Sweden, United Kingdom Series A, Series B, Seed Software, Information Technology, E-Commerce
Dawn Biopharma
VC Fund
2 Denmark, France, Belgium Seed, Series A, Series B Biotechnology, Health Care, Therapeutics
Bruce Linton
Angel
2 Canada, United States, Denmark Post-IPO Equity, Seed, Pre-Seed Cannabis, Health Care, Biotechnology $37k–$53M
Giampaolo Cagnin
Angel
2 Italy, Denmark Seed, Pre-Seed Biotechnology, Food and Beverage, Plant-Based Foods $4.2M–$7.8M
Megatrend Invest
VC Fund
2 Denmark Seed Biotechnology, Manufacturing $3.3M–$10M
Wellcome Trust
VC Fund
2 United States, United Kingdom, France Grant, Series C Biotechnology, Health Care, Medical $1.3M–$127M
FundersClub
VC Fund
2 United States, Canada, India Seed, Series A, Pre-Seed Software, SaaS, Information Technology $450k–$23M
Access all 314 investors in Denmark Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Novo Holdings
VC Fund · Hellerup, Hovedstaden, Denmark · 31 investments in Denmark Biotechnology startups

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Denmark, United Kingdom

Investor stats

  • Total investments: 335
  • Round size: Series A $9M–$120M; Series B $12M–$130M; Series C $30M–$118M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $165M in 2018

Portfolio highlights

  • AlloCure — AlloCure is a biotechnology company, develops cell therapies for the treatment of various kidney diseases, organ transplants, and multi-organ injuries. It offers biological therapeutics for acute kidney injuries. AlloCure is based in Burlington, Massachusetts. It has operations in Salt Lake City, Utah, and Hamburg, Germany.The company isdedicated to the development of off-the-shelf biological therapies to treat serious and debilitating diseases that afflict millions of people around the world. AlloCure's unique technology uses processed cells derived from human bone marrow to treat a wide variety of diseases. AlloCure was founded on the unique and proprietary technology developed by Dr. Christof Westenfelder and Dr. Axel Zander. Westenfelder and Zander are world-renowned scientists who have dedicated their careers to developing effective therapies for kidney disease. AlloCure has operations in Salt Lake City Utah and Hamburg Germany.
  • PTC Therapeutics — Translating Science. Transforming Lives.
  • Freeline — A leading biotechnology company focused on innovative liver directed gene therapies for bleeding disorders and other debilitating, chronic diseases
Show all investments...

BioInnovation Institute
VC Fund · Copenhagen, Hovedstaden, Denmark · 19 investments in Denmark Biotechnology startups

BioInnovation Institute is a biotechnology startup that offers entrepreneurs and researchers in life science. Early-stage life science start-ups are supported with up to 10 million DKK in funding, business acceleration, network, labs, and office space. It helps to early-stage start-ups within human health and planetary health. The startup'smission is to use its knowledge, network, funding, and infrastructure to incubate world-class life science and catalyze the commercialization of new solutions through start-ups.BioInnovation Institute was founded in 2018 and is based in Denmark.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Convertible Note, Pre-Seed, Debt Financing
  • Geography: Denmark, Germany, Switzerland

Investor stats

  • Total investments: 73
  • Round size: Pre-Seed $516k–$5.2M; Debt Financing $549k–$1.4M; Convertible Note $549k–$1.5M
  • Lead/follow: 90% lead, 10% follow

Portfolio highlights

  • Visibuilt — Visibuilt develops sustainable, bio-based asphalt binders made from mycelium. Replace fossil bitumen with visiBIT.
  • Loma Therapeutics — Loma Therapeutics is developing targeted immunotherapy for the effective and safe treatment of HPV infection, dysplasia, and cancer patients.
  • metaLead Therapeutics — metaLead Therapeutics is to develop this peptide as a next-generation Pb poisoning treatment.
Show all investments...

Vaekstfonden
VC Fund · Hellerup, Hovedstaden, Denmark · 16 investments in Denmark Biotechnology startups

Vaekstfonden – The Danish Growth Fund – is the Danish state's investment fund. We strive to improve access to risk capital to enable Danish businesses to innovate, and to generate growth and new jobs. In close collaboration with banks and domestic and international private investors, we finance companies from all sectors nation-wide. We canaccompany you for the entire journey – from your company’s infancy through growth phases to expansion abroad and even to an initial public offering.

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Seed, Pre-Seed
  • Geography: Denmark, United States, United Kingdom

Investor stats

  • Total investments: 196
  • Round size: Seed $810k–$4.6M; Pre-Seed $440k–$1.2M
  • Lead/follow: 28% lead, 72% follow

Portfolio highlights

  • Captego — Unique, high-speed field data capture. Empower your inspectors & surveyors with our unique collection app. Benefit from high quality data to automate reports and data insights.
  • LastSwab — LastSwab launched May 2019 through the crowdfunding platform Kickstarter. At $16 a swab, LastSwab is meant to last at least 1,000 uses and is the easy-to-clean, reusable alternative to the abundant waste caused by single-use swabs around the globe. The tip of the swab is made from medical silicone and nylon and comes in a biodegradable case made ofa corn-based material. LastSwab can be easily cleaned using soap and water and is also dishwasher safe. It comes in a standard swab for cleaning and a pointed swab for makeup application. Be the change and #SwabYourHabits.
  • Donkey Republic — Donkey Republic is leading bike share service in Europe with footprint in more than 10 key cities in Europe. We operate our locations with partners, and use custom-branded bikes. Our software backbone is developed by us with unique features that ensure we respect public space with our hub-centric service model. At the same time, we maximizepredictability of bike availability and convenience. We pride ourselves in service innovation.
Show all investments...

Export and Investment Fund
VC Fund · Hellerup, Hovedstaden, Denmark · 14 investments in Denmark Biotechnology startups

Denmark's Export and Investment Fund (EIFO) serves as a single point of contact for Danish firms seeking risk-tolerant government finance. We aspire to help successful enterprises that can expand the Danish economy and green the world on a daily basis, guided by professionalism and an international perspective.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: Denmark, United States, United Kingdom

Investor stats

  • Total investments: 119
  • Round size: Seed $390k–$11M; Series A $4.7M–$84M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • Woba — Woba is a SaaS aiming to support a stress-free work environment and minimise sick leave.
  • Embankment — Dedicated to AIFs. Driven by technology, delivered by domain experts
  • Landfolk — Landfolk is the new marketplace for the special holiday homes that are hidden around the country. We have hand-picked every single cottage, where there are proud and passionate hosts, who love their holiday homes, but also like to share it with others.
Show all investments...

Seed Capital
VC Fund · Copenhagen, Hovedstaden, Denmark · 9 investments in Denmark Biotechnology startups

Seed Capital invests in Danish tech businesses with global ambitions. We are focused on "late seed"-stage companies, typically investing 1-3 MEUR in rounds of 1-6 MEUR. Proud backers of Trustpilot, Vivino, Lunar, Templafy, Dixa, Forecast, and many other great companies.

Show more...

Investment focus

  • Industry: Software, Health Care, SaaS
  • Stage:Seed, Series A
  • Geography: Denmark, United States, United Kingdom

Investor stats

  • Total investments: 186
  • Round size: Seed $515k–$5M; Series A $3.5M–$17M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely still investing — raised $73M in 2021

Portfolio highlights

  • Cardlay — Build your own white-label card and expense management solution with Cardlay. Our platform helps banks, fleets, and tech partners launch modern spend management solutions fast.
  • Flatpay — Flatpay's fair, flat-rate pricing simplifies payments & cuts costs. Benefit from our comprehensive solution & superior customer service. Join us now!
  • Odendo — On Odendo you can make a great deal on exciting products while supporting a good cause
Show all investments...

PSV
VC Fund · Lyngby, Hovedstaden, Denmark · 8 investments in Denmark Biotechnology startups

PSV cares about a conscious future. As a venture house, our mission is to clear the path for founders who build companies that matter. Our hybrid setup, comprising PSV Foundry, PSV Lab, and two unique venture funds, PSV Tech and PSV Hafnium, sets us free from adhering to a singular method. Rather we rethink existing ways and models to maximise our impact beyond any individual firm or investment. Together, we can punch above our weight.

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Seed, Pre-Seed
  • Geography: Denmark, United States, United Kingdom

Investor stats

  • Total investments: 138
  • Round size: Seed $500k–$4.7M; Pre-Seed $88k–$2.5M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — raised $42M in 2020

Portfolio highlights

  • Viio — Oveo creates cloud-based software that enables any company in any industry to easily discover, manage, optimise and secure all SaaS usage from one platform.We believe employees should be able to enjoy work, be agile, move fast and in turn become more innovative on behalf of the companies they work for. In a subscribed economy a “SaaS-Poweredworkplace” is the enabling foundation to make that vision come true and at Oveo we proud to contribute by making SaaS usage more transparent, manageable and secure. Theircloud-based software enable companies to easily push this transformation and as SaaS adoption continues to skyrocket we will be right here with you - building the platform to manage and optimize the lifecycle of your SaaS applications.
  • Woba — Woba is a SaaS aiming to support a stress-free work environment and minimise sick leave.
  • Legal Monster — Openli makes privacy transparent. Get control of your data processors and keep your DPAs up to date. Build trust and close deals faster all with Openli.
Show all investments...

Sunstone Life Science Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 6 investments in Denmark Biotechnology startups

Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: Denmark, Sweden, Switzerland

Investor stats

  • Total investments: 56
  • Round size: Series A $5.5M–$43M; Series B $9.6M–$52M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: May invest from a new fund soon — raised $94M in 2019

Portfolio highlights

  • Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
  • Synendos Therapeutics — Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.
  • TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Show all investments...

Oskare Capital
VC Fund · Paris, Ile-de-France, France · 6 investments in Denmark Biotechnology startups

Oskare Capital is a venture capital firm.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Italy, Denmark, United Kingdom

Investor stats

  • Total investments: 8
  • Round size: Seed $1.2M–$3.9M; Series A $4.8M–$5.9M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Leva Clinic — Leva Clinic offers health care services for people with chronic pain. Their medical services include back pain, cancer pain, endometriosis, facial pain, fibromyalgia, joint pain, knee pain, multiple sclerosis, sciatica, and so on.
  • Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
  • Herbolea Biotech — Unique bio-processing technologies NATURAL, SOLVENT-LESS Botanical extraction Learn more
Show all investments...

Gilde Healthcare
VC Fund · Utrecht, Utrecht, The Netherlands · 6 investments in Denmark Biotechnology startups

Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million ($900 million) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcareservices. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series C, Series A
  • Geography: United States, The Netherlands, Germany

Investor stats

  • Total investments: 127
  • Round size: Series A $8.8M–$65M; Series B $15M–$120M; Series C $21M–$75M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: Likely still investing — raised $786M in 2023

Portfolio highlights

  • Okami Medical — Okami Medical is a medical device company with a mission to address the evolving needs of patients and physicians through the development of innovative, versatile, and intuitive devices for the occlusion of peripheral vessels.
  • ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
  • Endovascular Engineering — Endovascular Engineering is a preclinical stage company developing novel mechanical thrombectomy solutions to address peripheral indications.
Show all investments...

Nordic Foodtech VC
VC Fund · Helsinki, Southern Finland, Finland · 6 investments in Denmark Biotechnology startups

We are investing in #FutureFood. Nordic FoodTech VC is the first fund in the Nordics investing explicitly in the future of food

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Life Science
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Finland, Denmark, Sweden

Investor stats

  • Total investments: 28
  • Round size: Seed $549k–$5.5M; Pre-Seed $1M–$1.9M; Series A $7.4M–$18M
  • Lead/follow: 54% lead, 46% follow
  • Last fund: Likely still investing — raised $49M in 2021

Portfolio highlights

  • Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.
  • Hailia Oy — We mainstream seafood sidestreams with technology that upcycles them into tasty food products.
  • NPHarvest — NPHarvest is a company with expertise in organic waste management, wastewater treatment, and nutrient recovery. NPHarvest is a research project aiming to enable efficient and profitable nitrogen recycling from waste flows to the fertilizer market, utilizing energy-efficient hydrophobic membrane stripping and ballasted sedimentation of phosphoruswith lime.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
RA Capital Management
VC Fund · Boston, Massachusetts, United States · 5 investments in Denmark Biotechnology startups

RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. The company's team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and boardlevels. The company invests in companies with promising technologies and products.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series C, Post-IPO Equity
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 448
  • Round size: Series B $26M–$152M; Series C $40M–$200M; Post-IPO Equity $34M–$235M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Curevo — focused on a new generation of adjuvanted subunit vaccines Learn More Our Focus We're dedicated to developing non-mRNA vaccines for unmet medical needs Curevo Vaccine is a clinical-stage biotech company dedicated to developing next-generation non-mRNA vaccines. We focus on one need at a time, allowing us to bring effective and better-tolerated vaccines to market quickly
  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • Terrestrial Bio — Vaxess engineers novel technologies that uniquely engage the human immune system, enabling improved efficacy and simplified access for vaccines and therapeutics.
Show all investments...

West Hill Capital
VC Fund · London, England, United Kingdom · 4 investments in Denmark Biotechnology startups

West Hill Corporate Finance is a leading private equity venture capital firm providing EIS qualifying high-growth investments to private individuals.

Show more...

Investment focus

  • Industry: Software, Health Care, Financial Services
  • Stage:Series A, Seed
  • Geography: United Kingdom, Denmark, Germany

Investor stats

  • Total investments: 58
  • Round size: Seed $2.6M–$5.9M; Series A $1.8M–$15M
  • Lead/follow: 83% lead, 17% follow

Portfolio highlights

  • Cercare Medical — Cercare Medical designs and develops a software tool for supporting acute stroke management, helping clinicians to evaluate the effect of a stroke. The software draws up the infarct-area within 30 seconds, locate perfusion area from images within 30 seconds and evaluate mismatch and generate a volume number of salvageable tissue. Cercare Medicalwas incorporated in 2013 under the name Combat Stroke and is based in Denmark.
  • ATLANT 3D — Micro and nanodevices are built and tested within days instead of months or years.
  • Formalize — A Whistleblower Software system made for accountants and lawyers that have clients, the whistleblower software system helps businesses implement a compliant solution that is both secure and transparent. their products are reporting links, case management, partner account they have designed a journey that makes feel safe about the process. AWS ishandling the physical security of the infrastructure, whistleblower software takes the shared responsibility of security between our cloud infrastructure and application seriously.
Show all investments...

DSM Venturing
VC Fund · Heerlen, Limburg, The Netherlands · 4 investments in Denmark Biotechnology startups

Innovators in nutrition, health, and beauty. Together, we bring progress to life by combining the essential, the desirable, and the sustainable.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Series A, Series B
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 92
  • Round size: Series A $3.5M–$32M; Series B $4.1M–$30M
  • Lead/follow: 51% lead, 49% follow
  • Last fund: May invest from a new fund soon — last raise in 2012

Portfolio highlights

  • Vivici — Our mission is to meet the world's growing need for sustainable, nutritious and great tasting animal-free proteins.
  • Verdezyne — Verdezyne was a privately-held company that employs its biological expertise and proprietary advanced computational algorithms to design and synthesize novel, high-diversity gene libraries for engineering proteins, metabolic pathways, and microorganisms. The company creates and harnesses this unique biological diversity to optimize commercialfermentation processes for the production of petrochemical replacements.
  • NutriLeads — NutriLeads is an innovative startup that develops nutritional ingredients with demonstrated health effects. NutriLeads aims to catalyze nutritional health innovation in the food industry by partnering with relevant companies to identify promising lead ingredients, develop sustainable and commercially viable production processes, and initiatescientific & clinical programs to substantiate the health effects of these ingredients. Together we will bring the benefits of the proprietary ingredients to patients and consumers.
Show all investments...

HealthCap
VC Fund · Stockholm, Stockholms Lan, Sweden · 4 investments in Denmark Biotechnology startups

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: United States, Sweden, France

Investor stats

  • Total investments: 126
  • Round size: Series A $5.7M–$55M; Series B $12M–$88M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $209M in 2019

Portfolio highlights

  • Positrigo — NeuroLF is an ultra-compact brain Positron Emission Tomography system. Our technology makes functional imaging accessible for people worldwide.
  • Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
  • Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Show all investments...

PINC
VC Fund · Stockholm, Stockholms Lan, Sweden · 4 investments in Denmark Biotechnology startups

PINC was launched as Paulig Incubator in 2018 to help Paulig stay in the forefront of relevant innovations, as well as to contribute to a tastier, healthier and more sustainable planet. Today, our ambition is the same, but we have developed into a corporate venture arm. We aim for strategic, financial, and societal impact in our investments,fostering a sustainable food system for tomorrow. We are investing across the agrifood value chain in three primary impact themes: Improve planetary health and diet within the current food system: This includes innovations in agriculture and food security, such as advanced crop breeding or green fertilizers, innovative ingredients and next generation healthy foods, as well as solutions for tracking and improving climate and nature. Novel technologies to feed 10 BN people by 2050: Technologies needed to sustainably produce enough food for our growing population. This includes food production without land use change, such as precision fermentation and cell-culture. A circular system for food & materials: Regardless of whether we grow our food in soil or in bioreactors, the system needs to be circular. Some examples are upcycled ingredients, food from unused sources, new coating and packaging solutions, as well as technologies to prevent or make better use of side streams. We are looking for entrepreneurs in an attractive market space with an intrinsic drive to find a solution to the problem they are addressing, a clear and scalable plan for success, a reliable team and partners whom we can trust and work closely with.

Show more...

Investment focus

  • Industry: Biotechnology, Agriculture, Food and Beverage
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Sweden, Denmark, United Kingdom

Investor stats

  • Total investments: 21
  • Round size: Seed $823k–$7M; Pre-Seed $549k–$2.8M; Series A $4.1M–$7.4M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • Scindo — Creating a novel biological process to turn low-value plastic landfill waste into high-value molecules.
  • EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
  • BlueRedGold — Discover BlueRedGold - the home of exquisite Swedish Saffron, ethically grown and harvested with precision in Sweden. Experience the unparalleled quality of our saffron, perfect for culinary enthusiasts and chefs alike. Join us in embracing sustainable luxury.
Show all investments...

Ysios Capital
VC Fund · San Sebastian, Pais Vasco, Spain · 4 investments in Denmark Biotechnology startups

Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Spain, United States, Switzerland

Investor stats

  • Total investments: 79
  • Round size: Series A $2.2M–$63M; Series B $17M–$135M; Series C $27M–$80M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • VarmX — VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable ofimmediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban.These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
  • Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
  • Cytoki Pharma — Cytoki Pharma is a biotechnology company developing a portfolio of IL-22-based drugs as a new treatment paradigm for serious diseases involving epithelial injury.
Show all investments...

ACME Capital
VC Fund · San Francisco, California, United States · 4 investments in Denmark Biotechnology startups

ACME Capital is a venture capital and private equity firm that invests in breakthrough technologies that fuel platform shifts and disruptive business models that capitalize on new platforms. Its purpose is to support those founders who choose to take their capital. The firm was founded in 2018 and headquartered in San Francisco, California.

Show more...

Investment focus

  • Industry: Software, Health Care, Mobile
  • Stage:Seed, Series A, Series B
  • Geography: United States, Denmark, Canada

Investor stats

  • Total investments: 171
  • Round size: Seed $1.6M–$8.6M; Series A $4.4M–$30M; Series B $15M–$70M
  • Lead/follow: 23% lead, 77% follow
  • Last fund: Likely still investing — raised $300M in 2022

Portfolio highlights

  • Cue — Cue helps users track their health at the molecular level, revealing the interplay of activity, food, and sleep. Consumers can track 5 key health and lifestyle indicators: inflammation, vitamin D, fertility, influenza, and testosterone in just minutes, at home. Cue sends the data via Bluetooth 4.0 to the user's smartphone, where the free Cueapp reveals the interplay of activity, food, and sleep shaping the user at a molecular level.
  • NexGenT — Launch Your IT Career in Networking or Cyber Security Online With Our Military Grade Inspired Next Generation Training Programs. Go From Zero To Engineer within 6 months! Zero Up Front Tuition Options Available!
  • BoomPop — Work culture resources, virtual event inspiration, team building ideas, and fresh perspectives on the future work, brought to you by the BoomPop team.
Show all investments...

VF Venture
VC Fund · 4 investments in Denmark Biotechnology startups

Vaekstfonden makes equity investments in Danish companies with a track record as well as in young entrepreneurial, innovative enterprises with an ambition for global growth.

Show more...

Investment focus

  • Industry: Software, SaaS, Biotechnology
  • Stage:Seed, Series A
  • Geography: Denmark, United Kingdom, Iceland

Investor stats

  • Total investments: 29
  • Round size: Seed $1.2M–$9.1M; Series A $5.6M–$22M
  • Lead/follow: 31% lead, 69% follow

Portfolio highlights

  • Tame — ABOUT With Tame you can fully customise your virtual events, and make them fun, engaging & exciting to attend.- Apply your branding: Customise your virtual event completely - Personalised Welcome: Personal welcome message when attendees enter - Multiple stages: Broadcast content across multiple stages. - Live streaming: Stream live via anybroadcasting software - Pre-recorded videos: Broadcast pre-recorded videos as if it was live - Breakout sessions: Enable public or private breakout sessions. - Virtual Sponsor booths: Allow attendees to engage with sponsors live. - Customise Chat: Allow for 1:1 chat, group chat or session chat. - 1:1 Video Meetings: Empower social networking virtually.OUR COMPANY We are an experience-centric company, and we believe in the power of great experiences. 
 Our international group of dreamers, creators and rule-breakers passionate about merging design and technology together, enables us to transform that into one truly amazing event platform.OUR PEOPLE The team behind Tame has an aggregated decades long experience of creating events and building products that solve real problems for real people. So, what got us here? Our ambition to change a broken event industry through innovation, customer obsession and a relentless focus on the great experience.
  • Kollektiv — Unleash your best self with tailored training plans, learning and support for running, swimming and cycling - from world-class-coaches and ex-athletes.
  • Performativ — Performativ develops modern solutions for the asset and wealth management industry. Our clients span from small investment advisors to enterprise banks.
Show all investments...

Per Falholt
Angel · Copenhagen, Hovedstaden, Denmark · 4 investments in Denmark Biotechnology startups

A passion and vision for chemistry and biotechnology led Per (born 1958) to Novo A/S, where he started his career as a research chemist. He subsequently held several managerial positions developing products for the detergent industry and rose to Director for Application Technology in the company’s new enzyme development division in 1995.Hemoved to Raleigh, N.C., to head the company’s U.S. application technology unit in 1997, returning to Denmark three years later as Corporate Vice President of the Enzyme Development and Application division. In April 2000, Per merged the Research and Development division into the newly formed Enzyme Business R&D.Per assumed his current position following Novozymes’ demerger from Novo Nordisk in 2000. As chief science officer, he has helped Novozymes develop a unique industrial biotechnology platform which delivers solutions to meet customer needs and support growth.Per holds a M.Sc. in Chemical Engineering from Technical University of Denmark (DTU). Committed to promoting education and research within the sciences, he was appointed Honorary Professor at DTU’s Institute for Systems Biology in 2010 and became Chairman of the Board in 2013. He is also Chairman of the Young Scientists association in Denmark.Per’s current external positions also include Chairman, DTU, board member of DHI Group, board member of ARTs Biologics A/S, and member of the Danish Council for Research Policy.

Show more...

Investment focus

  • Industry: Biotechnology, Robotics, Biopharma
  • Stage:Pre-Seed, Series A, Seed
  • Geography: Denmark

Investor stats

  • Total investments: 5
  • Round size: Series A $5.9M–$20M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Visibuilt — Visibuilt develops sustainable, bio-based asphalt binders made from mycelium. Replace fossil bitumen with visiBIT.
  • Reshape Biotech — Fully digital microbiology developed by Reshape Biotech
  • Synamics Therapeutics — Synamics Therapeutics uses AI and predictive modeling for precision oncology and improved drug discovery. Our adaptive medicine approach helps prolong drug effectiveness and improves outcomes for patients with intractable cancers. Learn more about Synamics Therapeutics and how we leverage AI for personalized, adaptive cancer therapies.
Show all investments...

EIR Ventures
VC Fund · Stockholm, Stockholms Lan, Sweden · 3 investments in Denmark Biotechnology startups

EIR Ventures is a new Life Science Venture Group in the Nordics.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Seed
  • Geography: Denmark, Sweden, United States

Investor stats

  • Total investments: 12
  • Round size: Series A $20M–$73M
  • Lead/follow: 58% lead, 42% follow
  • Last fund: Likely still investing — raised $143M in 2021

Portfolio highlights

  • Henlez — Henlez is a Danish startup company.
  • Synklino — Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection. The company's immunotoxin is highly effective, potent and fast-acting that kills lytic and latently infected cells, enabling patients to have long-term health benefits for transplantation.
  • Galecto — Damora Therapeutics is working to fundamentally redefine care for people with blood disorders by bringing forward optimized therapies that dramatically improve patient outcomes.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Blue Horizon Corporation
VC Fund · Zürich, Zurich, Switzerland · 3 investments in Denmark Biotechnology startups

Blue Horizon is accelerating the transition to a sustainable food system that delivers outstanding returns for the planet and people.

Show more...

Investment focus

  • Industry: Food and Beverage, Food Processing, Biotechnology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 94
  • Round size: Seed $2M–$12M; Pre-Seed $450k–$6.3M; Series A $2M–$28M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — raised $187M in 2021

Portfolio highlights

  • WOW EARN — Discover WOW EARN, the all-in-one Web3 app with crypto mining, multi-chain wallet, staking NFTs, and marketplace dApps. Join the global Web3 community today.
  • EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.
  • foodforecast — AI supported solution to reduce food waste.
Show all investments...

Ugly Duckling Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 3 investments in Denmark Biotechnology startups

At Ugly Duckling Ventures, we make capital, know-how, and real-world application available to Nordic ventures at the seed & pre-seed stage. We are operational by nature and want to get in the grind as we excel at getting early-stage ventures ready for scale.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Pre-Seed
  • Geography: Denmark, Sweden, Finland

Investor stats

  • Total investments: 18
  • Round size: Seed $876k–$5.5M; Pre-Seed $917k–$1.7M
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Eupry — Be in full control of your temperature compliance at all times. Collect temperature monitoring, mapping, and calibration in one GxP-compliant solution.
  • Unioo — Unioo is a board portal that develops tools and software solutions to revolutionize and manage organizations and volunteer work.
  • Kollektiv — Unleash your best self with tailored training plans, learning and support for running, swimming and cycling - from world-class-coaches and ex-athletes.
Show all investments...

HTGF (High-Tech Gruenderfonds)
VC Fund · Bonn, Nordrhein-Westfalen, Germany · 3 investments in Denmark Biotechnology startups

High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 557
  • Round size: Seed $994k–$7.4M; Series A $3M–$40M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — raised $522M in 2022

Portfolio highlights

  • QphoX — QphoX builds quantum modem device, connecting quantum computers across a quantum network.
  • Zimory — Founded in 2007, Zimory provides carrier-grade cloud infrastructure management software that allows service providers, enterprises and cloud brokers to fully leverage the power and elasticity of cloud computing. Zimory’s intelligent Cloud Suite simplifies, automates and expedites the creation, launch and management of all types of cloudenvironments – whether public, private, virtual private or hybrid. Zimory software is also a key enabler of cloud marketplaces for enterprise services, applications and infrastructure. Headquartered in Berlin, Zimory has development centers in Erfurt, Germany and Minsk, Belarus, a subsidiary office in New York City and is expanding its expertise and presence globally.
  • BlueID GmbH — Smart locks for professionals. BlueID delivers flexible, secure and convenient smart locks for all doors in and around your office.
Show all investments...

The Footprint Firm
VC Fund · Copenhagen, Hovedstaden, Denmark · 3 investments in Denmark Biotechnology startups

The Footprint Firm is an advisory and investment company with a sole focus on sustainability.

Show more...

Investment focus

  • Industry: Software, Renewable Energy, Energy Management
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Denmark, Spain, Norway

Investor stats

  • Total investments: 23
  • Round size: Seed $730k–$5.5M; Pre-Seed $775k–$4M; Series A $4.8M–$18M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • FoodOp — Helping chefs cut food costs, reduce admin work, and drive sustainability. Menu planning, procurement, and reporting in one place.
  • LastSwab — LastSwab launched May 2019 through the crowdfunding platform Kickstarter. At $16 a swab, LastSwab is meant to last at least 1,000 uses and is the easy-to-clean, reusable alternative to the abundant waste caused by single-use swabs around the globe. The tip of the swab is made from medical silicone and nylon and comes in a biodegradable case made ofa corn-based material. LastSwab can be easily cleaned using soap and water and is also dishwasher safe. It comes in a standard swab for cleaning and a pointed swab for makeup application. Be the change and #SwabYourHabits.
  • Reel Energy — Reel empowers all companies to procure renewable electricity that makes a real difference for the climate.
Show all investments...

Thia Ventures
VC Fund · Genève, Geneve, Switzerland · 3 investments in Denmark Biotechnology startups

WE ARE AN EARLY-STAGE INVESTOR IN ONE OF THE MOST DYNAMIC AND ESSENTIAL FIELDS OF CURRENT HUMAN ENDEAVOR WE BRING ROBUST INVESTOR MUSCLE TO EARLY-STAGE VENTURES INVESTOR A specialized and focused investor Resources Powerful industry, substance and business resources Experience Wide networks and longstanding experience Team Yet, adaptability and speed of a lean, self-financed team

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Food and Beverage
  • Stage:Series A, Seed, Series B
  • Geography: United States, France, Denmark

Investor stats

  • Total investments: 20
  • Round size: Seed $3.3M–$20M; Series A $6.3M–$53M; Series B $24M–$50M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
  • uFraction8 — Multi-award-winning, innovative, microfluidics-based filter systems to provide bio-manufacturers with energy-efficient & ultra-scalable bioprocessing systems.
  • Clever Carnivore — Clever Carnivore is a cell-cultured meat startup that uses stem cell biology, recombinant protein, and bioengineering to create cost-effective lab grown meats. With the company's high-efficiency model, cruelty-free, environmentally friendly, and cost-competitive technology it aims to produce sausage, burgers, and chicken nuggets.
Show all investments...

NOON Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 3 investments in Denmark Biotechnology startups

Noon Ventures is a Copenhagen-based, early-stage venture investor established in 2020. We invest in proven transformative technologies with the potential to impact environmental or climate challenges.

Show more...

Investment focus

  • Industry: Biotechnology, AgTech, Farming
  • Stage:Seed, Series A
  • Geography: Denmark

Investor stats

  • Total investments: 6
  • Lead/follow: 83% lead, 17% follow

Portfolio highlights

  • Agrobiomics — Agrobiomics is a danish Agritech start-up, harnessing the power of soil bacteria and their metabolites as new biostimulants to help crops cope with abiotic stress such as drought.
  • Enduro Genetics — Bioproduction can be difficult to scale to large cultivation volumes while keeping titers high. By applying game-changing synthetic biology technology, Enduro Genetics empowers our partner companies to maximize performance of all cells cultivated from their production strains.
  • Lotus Microsystems — Lotus Microsystems offers miniaturized highly integrated point of load power converters. The devices are engineered for portable electronics manufacturers ready for usage whenever tiny power supply units are needed. Our devices offer up to 72% reduction in footprint compared to existing solutions with higher efficiency and reliability. Our plug andplay solutions enable our customers to innovate their electronics without worrying about power supply units.
Show all investments...

Unconventional Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 3 investments in Denmark Biotechnology startups, 7 in the past 12 months

Unconventional Ventures invests in startups in the pre-seed and seed stage led by diverse founders identifying as women, people of color, immigrants and/or LGBTQ+, building scalable impact tech companies in the Nordics and beyond.

Show more...

Investment focus

  • Industry: Health Care, Software, Wellness
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Sweden, United Kingdom, Denmark

Investor stats

  • Total investments: 17
  • Round size: Seed $1M–$5.2M; Pre-Seed $1.5M–$2.8M; Series A $4.8M–$18M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Flox Intelligence — Wildlife intelligence for critical infrastructure.
  • AIRMO — Airmo is a space tech company that offers an independent data source that locates, quantifies, and tracks carbon dioxide and methane emissions through a small satellite constellation.
  • Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
Show all investments...

Karolinska
VC Fund · Solna, Stockholms Lan, Sweden · 3 investments in Denmark Biotechnology startups

Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Series A
  • Geography: Sweden, Denmark, United States

Investor stats

  • Total investments: 29
  • Round size: Series A $1.3M–$73M
  • Lead/follow: 31% lead, 69% follow

Portfolio highlights

  • BOOST Pharma — Boost Pharma: Developing a stem cell therapy for Osteogenesis Imperfecta.
  • Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
  • Umecrine Cognition — Umecrine Cognition is a Swedish clinical-stage pharmaceutical company developing a novel class of drugs to treat neurological disorders of the brain.
Show all investments...

Innovation Fund Denmark
VC Fund · Copenhagen, Hovedstaden, Denmark · 3 investments in Denmark Biotechnology startups

Innovation Fund Denmark invests in the development of new knowledge and technology creating growth and employment in Denmark. The Fund focuses on societal challenges, strengthens research, and increases innovation commitment within private companies.The Fund provides risk capital that enables cutting-edge initiatives to achieve resultssubstantially impacting the Danish society. Innovation Fund Denmark is also responsible for the future societal partnerships, where companies, universities, and public authorities will work together on challenges facing the society today.

Show more...

Investment focus

  • Industry: Software, Biotechnology, SaaS
  • Stage:Grant, Pre-Seed, Seed
  • Geography: Denmark, United States

Investor stats

  • Total investments: 89
  • Round size: Seed $66k–$1.3M; Grant $22k–$1.1M; Pre-Seed $64k–$1.6M
  • Lead/follow: 31% lead, 69% follow

Portfolio highlights

  • Prezio — Prezio is an electricity tariff data API for Europe. We aggregate, structure, and serve real-time and historical electricity pricing data - spot prices, retail tariffs, and grid fees - so energy applications don't have to build and maintain that data infrastructure themselves. Typical customers are developers and product teams building EVsmart charging, heat pump control, home batteries, and solar optimization tools - anything that needs to know what electricity actually costs, right now or over time, across European markets.
  • SureShot — SureShot empowers you and your audience to become video co-creators. With our cutting-edge AI, capture, edit, and share electrifying videos that amplify the essence of every event.
  • AlterEcho — AlterEcho is redefining aseptic manufacturing by decoupling human operators from cleanroom environments through First-Person View Remote Robotic Embodiment. Instead of direct intervention, operators control precision robotics remotely via first-person-view headsets and motion controllers, maintaining the dexterity and adaptability of humanoversight while eliminating contamination risks. This paradigm shift enables pharmaceutical manufacturers to enhance scalability, optimize facility layouts, and future-proof production against labor shortages and regulatory pressures. Unlike conventional automation, which struggles with edge cases and lengthy validation cycles, AlterEcho keeps human decision-making in the loop while generating the operational data and infrastructure that could enable more autonomous biomanufacturing in the future. A Techstars-backed venture, AlterEcho is not just iterating on aseptic workflows - it’s reengineering the fundamental relationship between humans and pharmaceutical production.
Show all investments...

Bioqube Ventures
VC Fund · Hasselt, Limburg, Belgium · 3 investments in Denmark Biotechnology startups

Bioqube Ventures is a specialist life sciences venture capital fund investing in European biotech companies developing innovative therapeutic assets and technologies. We put our venture creation experience at work to translate and de-risk scientific innovation, advancing our investment portfolio and maximising value for investors.Bioqube Venturesinvests through its independent fund “Bioqube Factory Fund I”: … an early stage venture capital fund – dedicated to advancing exciting science in vibrant European ecosystems to breakthrough therapies for patients.… a fit-for-purpose dual investment model – besides more classical investments in first investment rounds, we will have special attention for so called “Create” projects that require additional de-risking prior to creating new ventures. … a hands-on approach – the team is a mix of fund managers, sector experts and serial entrepreneurs that have a proven track record in successfully leading companies on their growth paths.Medtech, healthtech and diagnostics are not part of our current investment scope.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Life Science
  • Stage:Seed, Series A, Series B
  • Geography: United States, France, Norway

Investor stats

  • Total investments: 18
  • Round size: Seed $5.7M–$21M; Series A $4M–$76M; Series B $23M–$108M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • Actithera — Actithera is a molecular radiotherapeutic company that develops radioligand therapies. It translates medicinal chemistry insights into new radioligand therapies (RLTs) and applies various molecular design strategies, including covalent targeting and an isotope-agnostic philosophy, to invent RLTs with significant differentiation and largertherapeutic windows.
  • Commit Biologics — Add a description for facebook
  • Primmune Therapeutics — Primmune Therapeutics is developing small molecule, orally-administered toll-like receptor 7 (TLR7) agonists to attack tumors and potentiate adaptive cancer immunotherapies, such as checkpoint inhibitors, to improve overall response rates and treatment durability.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Nicholas Francis
Angel · Copenhagen, Hovedstaden, Denmark · 3 investments in Denmark Biotechnology startups

Nicholas Francis is Co-founder at framebunker

Show more...

Investment focus

  • Industry: SaaS, Robotics, Software
  • Stage:Seed, Series A
  • Geography: Denmark, United States

Investor stats

  • Total investments: 4
  • Round size: Seed $854k–$7.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Waterplan — Waterplan is a SaaS platform for companies to manage water availability in their facilities.
  • Reshape Biotech — Fully digital microbiology developed by Reshape Biotech
Show all investments...

Atlantic
VC Fund · Berlin, Berlin, Germany · 3 investments in Denmark Biotechnology startups

Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures.&nbsp;<br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.

Show more...

Investment focus

  • Industry: Software, Health Care, Financial Services
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 199
  • Round size: Seed $1.2M–$9.1M; Pre-Seed $850k–$3.8M; Series A $5.3M–$32M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Clue — Track your menstrual cycle with the Clue app, a women-led period and cycle tracker. Get science-based insights, predictions, and personalized tracking.
  • bonify — Bonify, a Berlin based FinTech-Start-up, enables customers to benefit from their credit scoring and financial data. The company gives customers free and easy access to their credit score and let them upload additional relevant data. Then, it offers tools and personalized recommendations to help optimize the customer’s financial situation.Foundedin 2015 by key executives of McKinsey and Zalando, bonify has received significant funding from internationally leading VCs and successful entrepreneurs.
  • tozero — Truly bringing lithium-ion battery waste tozero by recovering all critical matierlas, like lithium, nickel, cobalt, manganese, and graphite.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 3 investments in Denmark Biotechnology startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 309
  • Round size: Series A $6M–$67M; Series B $10M–$120M; Series C $12M–$100M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely still investing — raised $200M in 2023

Portfolio highlights

  • Elicit Plant — We work with farmers around the world to meet the challenges of climate change and the impact of water scarcity on field crops.
  • l'école — l'école AI is a computer vision-focused development platform. Its objective is to enable humans to use AI with purpose to change the future, beginning with a focus on speeding advances in life sciences using computer vision.
  • EndoRon Medical — Endoron Medical develops an endovascular suture, like a device for the effective treatment of an abdominal aortic aneurysm.
Show all investments...

Omega Funds
VC Fund · Boston, Massachusetts, United States · 3 investments in Denmark Biotechnology startups

We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 149
  • Round size: Series A $16M–$197M; Series B $35M–$162M; Series C $14M–$208M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Ousia Pharma — Ousia Pharma is paving the way for novel therapeutic strategies using peptide-drug-conjugates
  • Andrew Alliance — OneLab is laboratory software to design and execute liquid handling protocols. Pipette+ for manual liquid handling pipetting and Andrew+ the pipetting robot
  • NRG Therapeutics — energizing drug discovery in neurodegenerative diseases.
Show all investments...

Newtree Impact
VC Fund · Belgium, Wisconsin, United States · 2 investments in Denmark Biotechnology startups

We invest in disruptive and encouraging Agri-Food tech and Food Loss companies, reshaping our food systems in order to solve the current & future problems of production.

Show more...

Investment focus

  • Industry: Biotechnology
  • Stage:Seed
  • Geography: Denmark

Investor stats

  • Total investments: 4
  • Lead/follow: no public data

Portfolio highlights

  • EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
  • Yeastup — Yeastup transforms brewer's yeast into proteins & fibers for food & supplements. Contact us for sustainable ingredient solutions.
  • New School Foods — Salmon, made from plants. Clean label with ALL the Omega-3s, NONE of the mercury. Made in Canada.
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 2 investments in Denmark Biotechnology startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

Balderton Capital
VC Fund · London, England, United Kingdom · 2 investments in Denmark Biotechnology startups, 26 in the past 12 months

In the two decades since our founding, we have worked with hundreds of extraordinary European founders, and have raised eight funds totalling more than $3bn.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Series A, Series B, Series C
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 340
  • Lead/follow: no public data

Portfolio highlights

  • Agave Games — Agave Games is a mobile games publishing company and provides unique experiences
  • Grand Games — Grand Games is shaping the future of gaming by creating genre-defining games played by millions worldwide.
  • Lindus Health — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
Show all investments...

Aescap Venture
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 2 investments in Denmark Biotechnology startups

The Aescap funds invest in highly innovative publicly traded biotech/life sciences companies. We're able to select the promising companies

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Chemical
  • Stage:Series A, Series B
  • Geography: United Kingdom, Austria, Belgium

Investor stats

  • Total investments: 18
  • Lead/follow: no public data

Portfolio highlights

  • Orphazyme — Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja Jäättela and Thomas Kirkegaard Jensen from the Danish Cancer Society (Kræftens Bekæmpelse).Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.
  • Avantium — Build a sustainable future with Avantium. Leading the change in green chemistry and innovative solutions.
  • F-Star Therapeutics — F-star is a clinical stage biotech developing next generation immunotherapies to transform the lives of patients with cancer. We are developing transformational cancer immunotherapies for patients who have few remaining options.
Show all investments...

CAPNOVA
VC Fund · Aarhus, Midtjylland, Denmark · 2 investments in Denmark Biotechnology startups

They are an investment and development company providing capital, solid business experience and a strong network in order to turn innovative ideas into successful businesses. They cover all of Denmark from their offices in Aarhus, Roskilde, Copenhagen, Viborg and Kalundborg.

Show more...

Investment focus

  • Industry: Software, Information Technology, B2B
  • Stage:Seed, Pre-Seed
  • Geography: Denmark, United States, India

Investor stats

  • Total investments: 24
  • Round size: Seed $147k–$2.4M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Ulobby — Ulobby is an automated tool for stakeholder management and political monitoring
  • Mechanic Miner — Mechanic Miner is a 2D construction/survival game with mechanical steam-powered machines. You are stranded on a strange and forbidding planet, where survival is made difficult by hostile animals and plant life. From your home world you did bring a multitool, which is able to craft any kind of machine part - provided the requisite rawmaterials can be found. Relying solely on the technology you brought, you set out to explore a whole world. You can progress through the game by acquiring new types of steam-powered technology elements, that are necessary to delve deeper into the diverse biomes of the planet, and perhaps, ultimately, discover the means to escape. You can construct any kind of machine of your own design - and any kind of machine can be simulated by the game's physics engine - and of course, designs can be shared with your friends.
  • ResoTher Pharma — ResoTher Pharma is a privately held biotechnology company located in Copenhagen, Denmark. The company is focused on developing peptide-based drugs derived from the endogenous immunomodulator Annexin 1A as resolution therapy for diseases where neutrophil-driven inflammation plays a key pathological role.
Show all investments...

Symrise
VC Fund · Holzminden, Niedersachsen, Germany · 2 investments in Denmark Biotechnology startups

About 30,000 products - 6,000 customers in roughly 160 countries. First synthesis of vanillin in 1874.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pet
  • Stage:Series A, Seed
  • Geography: United States, Sweden, Denmark

Investor stats

  • Total investments: 6
  • Round size: Series A $4.2M–$7.4M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
  • Indevex AB — Indevex is a science-based and privately owned biotech company from Sweden. A natural and reliable partner, providing evidence based natural nutrition concepts based on the patented NGC™ Formula.
  • Bond Pet Foods — We make vegan and protein-rich pet food and treats formulated by board-certified veterinary nutritionists.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Novo Ventures
VC Fund · Bagsværd, Hovedstaden, Denmark · 2 investments in Denmark Biotechnology startups

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 79
  • Round size: Series A $8.5M–$74M; Series B $14M–$75M; Series C $13M–$143M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • PanOptica — PanOptica is a biopharmaceutical company developing a topical eye drop for the treatment of eye diseases caused by abnormal or leaky blood vessels.
  • Galera Therapeutics — Developing novel therapies that have the potential to reduce radiotherapy-induced toxicities and improve the anti-cancer efficacy of radiation therapy
  • Reneo Pharmaceuticals — OnKure Therapeutics - Writing the Next Chapter in Precision Medicines for Patients With Cancer
Show all investments...

Steen Riisgaard
Angel · 2 investments in Denmark Biotechnology startups

Steen Riisgaard

Show more...

Investment focus

  • Industry: Life Science, Therapeutics, Biotechnology
  • Stage:Pre-Seed
  • Geography: Denmark

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
  • Synamics Therapeutics — Synamics Therapeutics uses AI and predictive modeling for precision oncology and improved drug discovery. Our adaptive medicine approach helps prolong drug effectiveness and improves outcomes for patients with intractable cancers. Learn more about Synamics Therapeutics and how we leverage AI for personalized, adaptive cancer therapies.
Show all investments...

+ND Capital
VC Fund · San Mateo, California, United States · 2 investments in Denmark Biotechnology startups

+ND Capital (NanoDimension) is a venture capital firm founded in 2002 that invests in disruptive technologies across the life, physical, and data sciences.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series C, Series A
  • Geography: United States, Switzerland, Denmark

Investor stats

  • Total investments: 58
  • Lead/follow: no public data

Portfolio highlights

  • Vandria — At the vanguard of Mitochondrial research
  • Constructive Bio — Constructive is a ground-breaking method for creating wholly artificial genomes and rewriting the genetic code of living things.
  • PulseSight Therapeutics — PulseSight is an ophthalmology drug development company creating novel, non-viral gene therapies with minimally invasive delivery technology to address the unmet need for treatments against severe retinal diseases leading to blindness.
Show all investments...

Northzone
VC Fund · London, England, United Kingdom · 2 investments in Denmark Biotechnology startups, 24 in the past 12 months

Northzone is a multi-stage venture capital fund that seeks to invest in the healthcare, semiconductors, software, hardware, artificial intelligence, blockchain, and gaming industries.

Show more...

Investment focus

  • Industry: Software, Information Technology, E-Commerce
  • Stage:Series A, Series B, Seed
  • Geography: United States, Sweden, United Kingdom

Investor stats

  • Total investments: 278
  • Lead/follow: no public data

Portfolio highlights

  • Nivoda — Nivoda provides jewellery businesses with a simple solution to strengthen profits, increase efficiency and accelerate growth with its B2B diamond marketplace. Designed to save you time and money whilst giving you access to the world’s diamond supply at the best prices with zero inventory risk, Nivoda is trusted by thousands of retailers all overthe globe.
  • Tana — Tana is a software development company that reinvents how humans, teams, and computers work together. Tana was founded in 2020 and was headquartered in Oslo, Norway.
  • Berry Street — Nutrition therapy by registered dietitians covered by insurance.
Show all investments...

Dawn Biopharma
VC Fund · Wilmington, Delaware, United States · 2 investments in Denmark Biotechnology startups

Dawn Biopharma is a global investment firm of KKR.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Seed, Series A, Series B
  • Geography: Denmark, France, Belgium

Investor stats

  • Total investments: 7
  • Lead/follow: no public data

Portfolio highlights

  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • Antag Therapeutics — Antag Therapeutics operator of a biotechnology company intended to develop metabolic and anti-obesity therapeutic drugs.The company specializes in the development of peptide-based GIP receptor antagonist in order to monitor dietary-related metabolic diseases through the infusion, enabling the healthcare industry to decrease blood flow and lipiduptake in adipose tissue in an efficient manner.
  • Bambusa Therapeutics — Bambusa Therapeutics operates as biotechnology company, that focuses on developing bispecific antibodies.
Show all investments...

Bruce Linton
Angel · Ottawa, Ontario, Canada · 2 investments in Denmark Biotechnology startups

Mr. Linton is the founder of Canopy Growth Corporation (CGC) and co-founder of Tweed Marijuana Inc.Bruce’s primary focus has been to position cannabis brands in a competitive market and to raise the capital necessary to fund such operations. Bruce’s experience as a founder, CEO, and Board member across a wide variety of enterprises has influencedthe positive start of Canopy Growth, which to date has enjoyed market support for capital raises of over $150 million and the distinction of being the first company in the industry to be offered debt instruments by a federal lender. Bruce has led three M&A transactions valued over $500 million total since founding CGC. In addition to his leadership responsibility at Canopy Growth, Bruce is the CEO of communications company Martello Technologies. After beginning his career at Newbridge Networks Corporation, he has since held positions that include General Manager and Re-Founder of Computerland.ca, President and Co-Founder of webHancer Corp, and part of the establishing team at CrossKeys Systems Corporation. He was also part of the leadership team for the NASDAQ/TSX initial public offering at CrossKeys. Bruce has been responsible for the acquisition and/or disposition of over $600 million in business assets, and has established regular engagement with the World Bank and Asia Development Bank while focused on markets in India, Philippines, China, Peru, Colombia, Ecuador, Azerbaijan and Uzbekistan. He is the past Chairman of the Ottawa Community Loan Foundation, past Board Member and Treasurer of Canada World Youth past Board of Governor for Carleton University, past President of the Nepean Skating Club and past President of the Carleton University Students Association.

Show more...

Investment focus

  • Industry: Cannabis, Health Care, Biotechnology
  • Stage:Post-IPO Equity, Seed, Pre-Seed
  • Geography: Canada, United States, Denmark

Investor stats

  • Total investments: 8
  • Round size: Seed $1.8M–$5M; Post-IPO Equity $37k–$53M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Omura — Discover heat-not-burn technology with Omura's dry herb vaporizer devices. Explore sustainable vaping options for hemp & whole flower CBD.
  • MindMed — MindMed discovers, develops, and deploys psychedelic-inspired medicines to improve health, promote wellness, and alleviate suffering. Learn more about our medicines and therapies today.
  • Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
Show all investments...

Giampaolo Cagnin
Angel · 2 investments in Denmark Biotechnology startups

Giampaolo’s aim has always been to apply a disruptive approach to functional food ingredients and that’s how he founded Italiana Ingredienti in ’89 and Campus in ’05. Both companies have been acquired, Italiana Ingredienti by Chr. Hansen in ‘99 and Campus by Firmenich in ’18. Today he serves as Founder and Chairman at Hi-Food, an Italian companyproviding key functional ingredients to food companies, and as a business Angel Investor in several startups.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Plant-Based Foods
  • Stage:Seed, Pre-Seed
  • Geography: Italy, Denmark

Investor stats

  • Total investments: 3
  • Round size: Seed $4.2M–$7.8M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Chromologics — Chromologics produce natural sustainable colors. Our flagship product is ChromoRed which performs better than existing natural, red colorants. ChromoRed is also applicable with vegan, kosher and halal diets.
  • Dreamfarm — We are a team of food-lovers 100% made in Italy! We dreamt of a better, tastier, more sustainable future and decided to join forces to create something special.
Show all investments...

Megatrend Invest
VC Fund · 2 investments in Denmark Biotechnology startups

Megatrend Invest is an investment Firm.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing
  • Stage:Seed
  • Geography: Denmark

Investor stats

  • Total investments: 2
  • Round size: Seed $3.3M–$10M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Biograil — Biograil, founded in 2019 and led by CEO Karsten Lindhardt, is using injection molding to manufacture a device contained in a standard size capsule able to deliver active substances into the gastrointestinal wall. The Biograil device avoids mechanical moving components and makes use of the body’s own peristaltic forces to facilitate the delivery ofthe biologic efficiently into the gastrointestinal wall.
Show all investments...

Wellcome Trust
VC Fund · London, England, United Kingdom · 2 investments in Denmark Biotechnology startups, 8 in the past 12 months

Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Grant, Series C
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 121
  • Round size: Grant $1.3M–$8.9M; Series C $10M–$127M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — raised $319M in 2018

Portfolio highlights

  • System — System is a free, open, and living public resource that aims to explain how anything in the world is connected to everything else.
  • Lario Therapeutics — Lario Therapeutics is a biopharmaceutical firm that develops precision therapeutics for epilepsy and neurological disorders.
  • Ineffable Intelligence — Ineffable Intelligence develops machine learning systems that learn through interaction and experience. The company works on reinforcement learning approaches that allow models to improve by trial and error rather than relying on large human-generated datasets. Its core work centers on building a “superlearner,” a system designed to generateknowledge and skills by engaging with simulated or real environments.The organization develops algorithms and computational frameworks that support autonomous learning, experimentation, and decision-making processes. Its efforts involve designing AI models that can adapt, refine behavior, and solve complex problems through continuous feedback loops. The company’s research aims to expand how AI systems acquire knowledge and apply it across different domains.
Show all investments...

FundersClub
VC Fund · San Francisco, California, United States · 2 investments in Denmark Biotechnology startups

FundersClub focuses on Seed and early stage investments. Investments include Coinbase, Instacart, Flexport, Le Tote, Teespring, Memebox, GitLab.FundersClub is the world's first online venture capital platform. Backed by Y Combinator, First Round Capital, Spark Capital, Intel Capital, Draper, Andreessen Horowitz, Felicis Ventures, and more;FundersClub Inc. was founded in 2012 and is based in the United States.

Show more...

Investment focus

  • Industry: Software, SaaS, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 304
  • Round size: Seed $800k–$5.3M; Pre-Seed $450k–$1.7M; Series A $5.1M–$23M
  • Lead/follow: 5% lead, 95% follow
  • Last fund: May invest from a new fund soon — raised $448k in 2019

Portfolio highlights

  • Zingbus — zingbus.com - India's Largest Online Ac Bus Booking Platform Offers Ac Bus Travels, Book AC Volvo Bus Tickets at Best Rates. Easy Cancellation & Instant Refund.
  • Embrace — Stay informed with Embrace's mobile monitoring solutions. Optimize app performance & user experience with our comprehensive platform. Learn more now.
  • Gecko Robotics — To collect and make useful physical data in order to protect civilization's most critical infrastructure
Show all investments...

Biotechnology Investor funding in Denmark at a glance

Stats across 306 deals from 314 investors.

314
investors
in Denmark Biotechnology startups
306
deals
in Denmark Biotechnology startups
$4.5M
median round
in Denmark Biotechnology startups
47%
lead investors
lead at least one round
19%
Seed
most common funding stage
94/6
VC / Angel
share of investor count

Access all 314 investors in Denmark Biotechnology startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology Investors in Denmark investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 314 investors investing in Denmark Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists